Pulmonary hypertension in chronic kidney disease - epidemiology, consequences, and associated factors
International Journal of Development Research
Pulmonary hypertension in chronic kidney disease - epidemiology, consequences, and associated factors
Received 14th July, 2020; Received in revised form 19th August, 2020; Accepted 06th September, 2020; Published online 30th October, 2020
Copyright © 2020, Thushara Joy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pulmonary hypertension is a prevalent clinical condition in chronic renal patients can be present since the early stages of chronic kidney disease and several studies have correlated pulmonary hypertension with increased morbidity and mortality at different stages of chronic kidney disease, including post-transplantation. In chronic renal patients there are many possible causes because is high prevalence of left ventricular hypertrophy, diastolic dysfunction and left ventricular dysfunction resulting elevated left atrial pressures that would passively lead eventually pulmonary venous hypertension. Verified in this search a pooled prevalence PH was 36.3+/-10.5% hemodialysis and 20.7+/-8.8% CKD non dialysis. The principals associated factors were progressive with worsening renal function associated or not with cardiac dysfunction, hyperparathyroidism, hypervolemia and vascular calcifications.
